FDA approves Sanofi and Regeneron’s Kevzara for adult rheumatoid arthritis

Sanofi and Regeneron Pharmaceuticals’ drug Kevzara (sarilumab) has received the US Food and Drug Administration (FDA) approval to treat adult patients affected with moderately to severely active rheumatoid arthritis (RA).

Spotlight

Spotlight

Related News